Join our daily newsletter At The Bell to receive exclusive market insights
- Explosives company Orica (ORI) appoints Gordon Naylor as an independent, non-executive Director, effective from next month
- For more than 30 years, Mr Naylor held a range of senior leadership roles at Australia’s leading global biotech company CSL (CSL) including Chief Financial Officer for five years
- Orica Chairman Malcolm Broomhead says with Mr Naylor’s many years of global leadership experience at CSL, he will be a strong addition to the board and complement the future strategy of the company
- ORI last traded at $15.89
Orica (ORI) has appointed Gordon Naylor as an independent, non-executive Director, effective from April 1.
For more than 30 years, Mr Naylor held a range of senior leadership roles at Australia’s leading global biotech company CSL (CSL) including Chief Financial Officer for five years.
He was also President of Seqirus where he led a three-year turnaround of the business into a global influenza vaccines leader.
Orica Chairman Malcolm Broomhead said Mr Naylor would be a strong addition to the board and complement the future strategy of the company.
“He is an experienced business leader with a strong track record in growing businesses in challenging international environments,” he said.
“With his engineering background, and experience in global supply chain and international systems strategy and implementation, Gordon will bring valuable insights into Orica’s growth strategy, manufacturing network and broader operations.”
OIR shares last traded at $15.89.
